Abstract
Fifty-five patients with osteoarthritis, rheumatoid arthritis or spondyloarthritis, joint pain and other rheumatic-inflammatory disorders were treated with proglumetacin, at different doses, during 3-60 days. Assessment of therapeutic efficacy indicated 88.9% of good results. Joint pain progressively decreased during the whole period of observation. Tolerance was considered good or very good in 78% of patients.
| Translated title of the contribution | Proglumetacin: A flexible and wide-spectrum anti-rheumatic drug in clinical practice |
|---|---|
| Original language | Italian |
| Pages (from-to) | 1547-1551 |
| Number of pages | 5 |
| Journal | Minerva Medica |
| Volume | 74 |
| Issue number | 26 |
| Publication status | Published - 1983 |
ASJC Scopus subject areas
- Medicine(all)